3Adami S.Bisphosphonates in Prostate carcinoma.Cancer,1997,80(8):1646～1679. 被引量：1
4Hortobagyi GN,Theriault RL,Lipton A,et al.Long-term Prevention of skeletal complications of metactatic breast cancer with pamidronate:protocal 19 aredia breast cancer study group.Jclin Oncol,1998,16:2038～3044. 被引量：1
5Brunelli Mr,Einhorn TA.Medical management of osteoporosis fracture prevention.Clin Orthop,1998,348:15～21. 被引量：1
6Giuliani N,Girasole M,Pedtaizonia,et al.Alendronate stienulate mineralized uodule formationin human bone marrow culture.J Bone Miner Res,1995,10:171～174. 被引量：1
5LEE S, ROSEN. Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma [ J ]. Cancer, 2003,98 ( 8 ) : 1737-17d4. 被引量：1
6HARINCK H I J, PAPAPOULOS S E,BLANKSMA H J,et al. Paget's disease of bone :early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate ( APD ) [ J ]. BMJ, 1987,295 ( 8 ) : 1301 - 1305. 被引量：1
7ADAMI S,MIAN M,GATTI P,et al. Effects of two oral doses of alendronate in the treatment of pagets disease of bone [J]. Bone,1994,15(4) :415. 被引量：1
8CLEZARDIN P, GLIGOROV J, DELMAS P. Mechanisms of action of bisphos phonates on tumor ceils and prospects for use in the treatment of malignanl osteolysis [ J ]. Joint Bone Spine,2000,67( 1 ) :22-29. 被引量：1
9JONES J. Bisphosphonates may be useful in treatment of bone metastases [ J ]. J Natl Cancer Inst, 2001,93 ( 14 ) : 1052-1053. 被引量：1
10BUYSE G, SILBERSTEIN J, GOEMANS N, et al. Fibrodysplasia ossificans progressiva:still turning into wood after 300 years[J]. Eur J Pediatr ,1995 ,154 ( 9 ) :694-699. 被引量：1
